RETRACTION: LncRNA CASC15 promotes migration and invasion in prostate cancer via targeting miR-200a-3p (Retraction of Vol 23, Pg 8303, 2019)

被引：7
|
作者：
Zhang, C. [1 ]
Wang, G. -X. [1 ]
Fu, B. [1 ]
Zhou, X. -C. [1 ]
Li, Y. [1 ]
Li, Y. -Y. [1 ]
机构：
[1] Nanchang Univ, Affiliated Hosp 1, Dept Urol, Nanchang, Jiangxi, Peoples R China
来源：
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES | 2020年 / 24卷 / 13期
关键词：
D O I：
10.26355/eurrev_202007_21866
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：7215 / 7215
页数：1
相关论文
共 50 条
  • [21] RETRACTION: LncRNA TUG1 aggravates the progression of prostate cancer and predicts the poor prognosis (Retraction of Vol 23, Pg 4698, 2019)
    Xu, T.
    Liu, C. -L.
    Li, T.
    Zhang, Y. -H.
    Zhao, Y. -H.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (09) : 3057 - 3057
  • [22] RETRACTION: LncRNA NEAT1 Promotes Proliferation, Migration and Invasion via Regulating miR-296-5p/CNN2 Axis in Hepatocellular Carcinoma Cells (Retraction of Vol 12, Pg 9887, 2019)
    Li, Y.
    Ding, X.
    Xiu, S.
    Du, G.
    Liu, Y.
    ONCOTARGETS AND THERAPY, 2021, 14 : 5095 - 5095
  • [23] RETRACTION: MicroRNA-454-3p inhibits cervical cancer cell invasion and migration by targeting c-Met (Retraction of Vol 15, Pg 2301, 2018)
    Guo, Yan
    Tao, Min
    Jiang, Min
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2024, 27 (05)
  • [24] RETRACTION: Statement of Retraction: p38/p53/miR-200a-3p feedback loop promotes oxidative stress-mediated liver cell death (Retraction of Vol 14, Pg 1548, 2015)
    Xiao, Yongtao
    Yan, Weihui
    Lu, Lina
    Wang, Ying
    Lu, Wei
    Cao, Yi
    Cai, Wei
    CELL CYCLE, 2022, 21 (23) : 2559 - 2559
  • [25] RETRACTION: lncRNA PEG10 promotes cell survival, invasion and migration by sponging miR-134 in human bladder cancer (Retraction of Vol 114, art no 108814, 2019)
    Jiang, Fuquan
    Qi, Wenqian
    Wang, Yao
    Wang, Weihua
    Fan, Li
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 145
  • [26] RETRACTION: LncRNA BCAR4 promotes migration, invasion, and chemo-resistance by inhibiting miR-644a in breast cancer (Retraction of Vol 42, Pg 14, 2023)
    Wu, Tangwei
    Li, Xiaoyi
    Yan, Ge
    Tan, Zheqiong
    Zhao, Dan
    Liu, Shuiyi
    Wang, Hui
    Xiang, Yuan
    Chen, Weiqun
    Lu, Hongda
    Liao, Xinghua
    Li, Yong
    Lu, Zhongxin
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2023, 42 (01)
  • [27] RETRACTION: miR-522-3p Promotes Tumorigenesis in Human Colorectal Cancer via Targeting Bloom Syndrome Protein (Retraction of Vol 26, Pg 1113, 2018)
    Shuai, Feng
    Wang, Bo
    Dong, Shuxiao
    ONCOLOGY RESEARCH, 2020, 28 (09) : 977 - 977
  • [28] RETRACTION: Long noncoding RNA DARS-AS1 acts as an oncogene by targeting miR-532-3p in ovarian cancer (Retraction of Vol 23, Pg 2353, 2019)
    Huang, K.
    Fan, W. -S.
    Fu, X. -Y.
    Li, Y. -L.
    Meng, Y. -G.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (13) : 7211 - 7211
  • [29] RETRACTION: MiR-605-3p inhibits malignant progression of prostate cancer by up-regulating EZH2 (Retraction of Vol 23, Pg 8795, 2019)
    Pan, M. -Z.
    Song, Y. -L.
    Gao, F.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (05) : 2156 - 2156
  • [30] RETRACTION: Knockdown of lncRNA HULC inhibits proliferation, migration, invasion, and promotes apoptosis by sponging miR-122 in osteosarcoma (Retraction of Vol 119, Pg 1050, 2018)
    Kong, Daliang
    Wang, Yang
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2021, 122 (05) : 599 - 599
12345